EZH2 and melanoma: DNA methylation and enhancer of zeste homolog 2 (EZH2) activity were found to induce PD-1 resistance in melanoma by inhibiting IFN-γ transcription and the RAS and PI3K pathways’ subsequent functions [61, 62].